Oscar Health (OSCR) director David Plouffe receives 681 deferred stock units as fee
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Plouffe David reported acquisition or exercise transactions in this Form 4 filing.
Oscar Health, Inc. director David Plouffe received a grant of 681 deferred stock units on July 9, 2026 as board compensation. Each unit represents a right to receive one share of Class A common stock and was valued using the Class A closing price of $31.20 on that date.
The units were issued under the Amended and Restated Deferred Compensation Plan for Directors in lieu of cash retainer payments and are 100% vested on the grant date. They will be settled in cash or Class A shares, at the company’s discretion, within 45 days after specified events such as termination of service, a change in control, death, or disability. Following this grant, Plouffe holds 7,535 deferred stock units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Plouffe David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Unit | 681 | $31.20 | $21K |
Holdings After Transaction:
Deferred Stock Unit — 7,535 shares (Direct)
Footnotes (1)
- Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.
Key Figures
Deferred stock units granted: 681 units
Reference share price: $31.20
Deferred stock units after grant: 7,535 units
+1 more
4 metrics
Deferred stock units granted
681 units
Grant of deferred stock units on July 9, 2026
Reference share price
$31.20
Closing price of Class A common stock on July 9, 2026 used to calculate units
Deferred stock units after grant
7,535 units
Total deferred stock units held directly by David Plouffe after transaction
Settlement window
45 days
Units settled within 45 days after specified triggering event
Key Terms
Deferred Stock Unit, change in control, Amended and Restated Deferred Compensation Plan for Directors
3 terms
Deferred Stock Unit financial
"Each deferred stock unit represents a right to receive one share"
A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.
change in control financial
"within 45 days of the first to occur of (i) termination of service; (ii) a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated Deferred Compensation Plan for Directors financial
"pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors"
FAQ
What did Oscar Health (OSCR) director David Plouffe report on this Form 4?
David Plouffe reported the grant of 681 deferred stock units tied to Oscar Health Class A common stock on July 9, 2026. These units were received as board compensation in lieu of a cash retainer payment and are 100% vested on the grant date.
How many Oscar Health (OSCR) deferred stock units does David Plouffe hold after this transaction?
After the July 9, 2026 grant, David Plouffe holds 7,535 deferred stock units directly. Each deferred stock unit represents a right to receive one share of Oscar Health’s Class A common stock, subject to the plan’s settlement terms.
What is a deferred stock unit in the context of Oscar Health (OSCR)?
For Oscar Health, each deferred stock unit gives the holder a right to receive one share of Class A common stock. Settlement occurs in cash or shares, at the company’s discretion, after specified events like termination of service or a change in control.
At what price were David Plouffe’s Oscar Health (OSCR) deferred stock units valued?
The 681 deferred stock units were valued using the $31.20 closing price of Oscar Health’s Class A common stock on July 9, 2026. That price was used solely to calculate the number of units issued as compensation.
When will David Plouffe’s Oscar Health (OSCR) deferred stock units be settled?
The deferred stock units will be settled for cash or Class A shares, at Oscar Health’s discretion, within 45 days after the first of several events, including termination of service, change in control, death, or disability.
Why did David Plouffe receive Oscar Health (OSCR) deferred stock units instead of cash?
David Plouffe elected, under Oscar Health’s Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for his board service. This election converts his cash compensation into equity-linked units.